Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Trastuzumab × Head & Neck × Clear all

Phase

Status

Recruiting 4 Completed 3 Terminated 2 Withdrawn 1 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 68 Gastrointestinal 22 Tumor-Agnostic 4 Thoracic 2 Other solid neoplasm 2 CNS 2 Head & Neck 1 Gynecologic 1 Genitourinary 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1

Interventions

Cisplatin 98 Docetaxel 41 Radiotherapy 36 Radiotherapy, Intensity-Modulated 32 Fluorouracil 27 Gemcitabine 26 toripalimab 19 apatinib 18 camrelizumab 17 Cetuximab 16 Paclitaxel 15 Drug Therapy 15 Carboplatin 15 Capecitabine 13 sintilimab 11 nimotuzumab 10 Surveys and Questionnaires 10 Endostatins 10 Chemoradiotherapy 10 pembrolizumab 9 durvalumab 9 Blood Specimen Collection 9 nedaplatin 8 endostar protein 8 Surgical Procedures, Operative 8 Induction Chemotherapy 8 Radiation 7 Cyclophosphamide 7 fludarabine 6 Thyroidectomy 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06130007 2023-11-13

B2023-153

Sun Yat-sen University

Phase 2 Unknown

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon ⚡